Trevi Therapeutics (TRVI) Earnings
|
Expand Research on TRVI
| Next EPS Date | 8/6/26 | EPS Growth Rate | -11.1% |
|---|---|---|---|
| Average EPS % Beat Rate | +25.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/7/26 |
Q126 | N/A | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/17/26 | Q425 | -$0.06 | -$0.10 | +$0.04 | N/A | N/A | N/A |  | | Details | |
| 11/13/25 | Q325 | -$0.08 | -$0.10 | +$0.02 | N/A | N/A | N/A | | | Details | |
| 11/10/25 |
Q325 | N/A | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/25 |
Q325 | N/A | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/5/25 |
Q325 | N/A | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/7/25 | Q225 | -$0.09 | -$0.10 | +$0.01 | N/A | N/A | N/A | | | Details |
